Neonc Technologies Holdings, Inc. (NTHI) stock surged +1.23%, trading at $4.11 on NASDAQ, up from the previous close of $4.06. The stock opened at $4.00, fluctuating between $4.00 and $4.21 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 30, 2026 | 4.45 | 4.72 | 4.19 | 4.42 | 92.56K |
| Apr 29, 2026 | 4.40 | 4.59 | 3.87 | 4.30 | 109.15K |
| Apr 28, 2026 | 4.58 | 4.70 | 4.15 | 4.31 | 129.62K |
| Apr 27, 2026 | 5.07 | 5.22 | 4.51 | 4.61 | 110.88K |
| Apr 23, 2026 | 4.95 | 4.97 | 4.51 | 4.79 | 68.87K |
| Apr 22, 2026 | 5.13 | 5.13 | 4.93 | 4.95 | 26.36K |
| Apr 21, 2026 | 5.16 | 5.26 | 5.06 | 5.13 | 27.46K |
| Apr 20, 2026 | 5.19 | 5.40 | 5.04 | 5.17 | 32.65K |
| Apr 17, 2026 | 4.96 | 5.57 | 4.96 | 5.34 | 23.34K |
| Apr 16, 2026 | 5.11 | 5.11 | 4.88 | 5.02 | 38.38K |
| Apr 14, 2026 | 5.30 | 5.49 | 5.17 | 5.39 | 34.97K |
| Apr 13, 2026 | 5.50 | 5.52 | 4.99 | 5.30 | 73.35K |
| Apr 10, 2026 | 5.20 | 5.51 | 4.49 | 5.44 | 96.99K |
| Apr 09, 2026 | 5.40 | 5.40 | 4.97 | 5.12 | 55.3K |
| Apr 08, 2026 | 6.00 | 6.24 | 5.37 | 5.37 | 70.42K |
| Apr 07, 2026 | 5.93 | 6.04 | 5.36 | 5.82 | 63.71K |
| Apr 06, 2026 | 6.41 | 6.41 | 5.70 | 5.74 | 37.75K |
| Apr 02, 2026 | 5.96 | 6.23 | 5.48 | 5.95 | 98.51K |
| Apr 01, 2026 | 7.00 | 7.05 | 6.09 | 6.09 | 21.25K |
| Mar 31, 2026 | 6.89 | 7.12 | 6.85 | 7.01 | 42.19K |
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
| Employees | 8 |
| Beta | 2.39 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep